Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02855554 · ClinicalTrials.gov registry record · NA
Quantitative Cardiac Parametric Mapping
A NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT02855554: Recruiting NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease, sponsored by Medical University of South Carolina.
NCT02855554 is a NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02855554, a NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.
Conditions Studied
Interventions
- OTHER Cardiac Magnetic Resonance (CMR) imaging techniques
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2014-06-20 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT02855554 shows while recruiting
NCT02855554 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Cardiomyopathy, Myocarditis, Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Magnetic Resonance (CMR) imaging techniques is the first listed.
NCT02855554 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02855554 about?
NCT02855554 is a clinical study titled "Quantitative Cardiac Parametric Mapping". The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ische...
What is the current status of trial NCT02855554?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2014-06-20. Estimated completion is 2026-12.
What conditions does trial NCT02855554 study?
This clinical trial studies the following conditions: Cardiomyopathy, Myocarditis, Ischemic Heart Disease.
What interventions are being tested in trial NCT02855554?
The interventions under investigation include: Cardiac Magnetic Resonance (CMR) imaging techniques (OTHER).
Who is sponsoring clinical trial NCT02855554?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02855554 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02855554's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
- NCT03683680 · 240 participants · NA
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI